Cargando…

Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial

BACKGROUND: Rotaviruses are the most important cause of severe acute gastroenteritis worldwide in children <5 years of age. The human, G1P[8] rotavirus vaccine Rotarix™ significantly reduced severe rotavirus gastroenteritis episodes in a Phase III clinical trial conducted in infants in South Afri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steele, Andrew Duncan, Neuzil, Kathleen M, Cunliffe, Nigel A, Madhi, Shabir A, Bos, Pieter, Ngwira, Bagrey, Witte, Desiree, Todd, Stacy, Louw, Cheryl, Kirsten, Mari, Aspinall, Sanet, Van Doorn, Leen Jan, Bouckenooghe, Alain, Suryakiran, Pemmaraju V, Han, Htay Htay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462149/ https://www.ncbi.nlm.nih.gov/pubmed/22974466 http://dx.doi.org/10.1186/1471-2334-12-213

Ejemplares similares

Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: Analysis of clinical trials of human rotavirus vaccine
por: Cheuvart, Brigitte, et al.
Publicado: (2014)

Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
por: Cunliffe, Nigel, et al.
Publicado: (2014)

The human rotavirus vaccine Rotarix™ in infants: An integrated analysis of safety and reactogenicity
por: Buyse, Hubert, et al.
Publicado: (2014)

Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination
por: Steele, A. Duncan, et al.
Publicado: (2016)

Post-marketing safety surveillance conducted in Korea (2008–2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)
por: Shin, Son Moon, et al.
Publicado: (2016)

Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis
por: Han, Htay Htay, et al.
Publicado: (2016)

Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: A post-marketing surveillance study
por: Bravo, Lulu, et al.
Publicado: (2014)

Pharmacoeconomic Spotlight on Rotavirus Vaccine RIX4414 (Rotarix™) in Developed Countries
por: Plosker, Greg L.
Publicado: (2012)

Immunogenicity of rotavirus vaccine (Rotarix(TM)) in infants with environmental enteric dysfunction
por: Mwape, Innocent, et al.
Publicado: (2017)

Serotype G12 Rotaviruses, Lilongwe, Malawi
por: Cunliffe, Nigel A., et al.
Publicado: (2009)

Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC
por: Debellut, Frédéric, et al.
Publicado: (2020)

Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia
por: Mwila-Kazimbaya, Katayi, et al.
Publicado: (2017)

The evolving epidemiology of rotavirus A infection in Brazil a decade after the introduction of universal vaccination with Rotarix®
por: Carvalho-Costa, Filipe A., et al.
Publicado: (2019)

Epidemiological trends for hospital admissions for acute rotavirus gastroenteritis in Belgium following the introduction of routine rotavirus vaccination and the subsequent switch from lyophilized to liquid formulation of Rotarix(™)
por: RAES, M., et al.
Publicado: (2016)

Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
por: Singh, Tina, et al.
Publicado: (2022)

G8 rotaviruses with conserved genotype constellations detected in Malawi over 10 years (1997–2007) display frequent gene reassortment among strains co-circulating in humans
por: Nakagomi, Toyoko, et al.
Publicado: (2013)

Correction to: Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
por: Singh, Tina, et al.
Publicado: (2022)

Reaching every child with rotavirus vaccine: Report from the 10th African rotavirus symposium held in Bamako, Mali
por: Sow, Samba O., et al.
Publicado: (2017)

Comparative whole genome analysis reveals re-emergence of human Wa-like and DS-1-like G3 rotaviruses after Rotarix vaccine introduction in Malawi
por: Mhango, Chimwemwe, et al.
Publicado: (2023)

A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines
por: van Hoek, Albert Jan, et al.
Publicado: (2012)

Comparative analysis of the Rotarix™ vaccine strain and G1P[8] rotaviruses detected before and after vaccine introduction in Belgium
por: Zeller, Mark, et al.
Publicado: (2017)

Rotaviruses and Rotavirus Vaccines
por: Donato, Celeste M., et al.
Publicado: (2021)

Rotavirus and Other Viral Diarrhoea
por: Cunliffe, Nigel A., et al.
Publicado: (2014)

Correction: A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines
por: van Hoek, Albert Jan, et al.
Publicado: (2012)

Comparative Analysis of G1P[8] Rotaviruses Identified Prior to Vaccine Implementation in Pakistan With Rotarix™ and RotaTeq™ Vaccine Strains
por: Sadiq, Asma, et al.
Publicado: (2020)

Rotavirus infection in Saudi Arabia
por: Kheyami, Ali M., et al.
Publicado: (2006)

Duration and Density of Fecal Rotavirus Shedding in Vaccinated Malawian Children With Rotavirus Gastroenteritis
por: Bennett, Aisleen, et al.
Publicado: (2019)

Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial
por: Fellows, Tamika, et al.
Publicado: (2023)

Corrigendum: Comparative Analysis of G1P[8] Rotaviruses Identified Prior to Vaccine Implementation in Pakistan With Rotarix™ and RotaTeq™ Vaccine Strains
por: Sadiq, Asma, et al.
Publicado: (2020)

Evaluation of ROTARIX(®) Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
por: Laban, Natasha Makabilo, et al.
Publicado: (2023)

Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (Rotarix(TM)) Immunogenicity among Infants in Zambia
por: Chauwa, Adriace, et al.
Publicado: (2023)

Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix(®) and a Nanoparticle-Based Trivalent Rotavirus Vaccine Evaluated in Gnotobiotic Pig Models of G4P[6] and G1P[8] Human Rotavirus Infection
por: Hensley, Casey, et al.
Publicado: (2023)

Rotavirus.
por: Parashar, U D, et al.
Publicado: (1998)

The rotaviruses
por: Flewett, T. H., et al.
Publicado: (1978)

Rotavirus
Publicado: (2012)

Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: A randomized, placebo-controlled trial in China
por: Li, Rong-cheng, et al.
Publicado: (2014)

The rotavirus vaccine development pipeline
por: Kirkwood, Carl D., et al.
Publicado: (2019)

The efficacy and safety of rotavirus vaccines in countries in Africa and Asia with high child mortality
por: Henschke, N., et al.
Publicado: (2022)

Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants
por: Li, Rong-cheng, et al.
Publicado: (2015)

Incidence of Rotavirus and Circulating Genotypes in Northeast Brazil during 7 Years of National Rotavirus Vaccination
por: Gurgel, Ricardo Q., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fsgv29ahqiba02aiaqv75psp02